Your browser doesn't support javascript.
loading
Romosozumab or alendronate for fracture prevention in East Asian patients: a subanalysis of the phase III, randomized ARCH study.
Lau, E M C; Dinavahi, R; Woo, Y C; Wu, C-H; Guan, J; Maddox, J; Tolman, C; Yang, W; Shin, C S.
Afiliación
  • Lau EMC; Hong Kong Orthopaedic and Osteoporosis Center for Treatment and Research, 6th Floor, Tower 2, New World Tower, 18 Queen's Road Central, Hong Kong, Hong Kong. edith.lau@hkosc.org.
  • Dinavahi R; Amgen, Inc., Thousand Oaks, CA, USA.
  • Woo YC; Department of Medicine, University of Hong Kong, Queen Mary Hospital, 102 Pok Fu Lam Road, Pok Fu Lam, Hong Kong.
  • Wu CH; Department of Family Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Sheng Li Road, Tainan, Taiwan.
  • Guan J; UCB Pharma, Brussels, Belgium.
  • Maddox J; Amgen, Inc., Thousand Oaks, CA, USA.
  • Tolman C; Amgen Asia Holding Ltd, One Island East, 18 Westlands Rd, Quarry Bay, Hong Kong.
  • Yang W; Amgen, Inc., Thousand Oaks, CA, USA.
  • Shin CS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Osteoporos Int ; 31(4): 677-685, 2020 Apr.
Article en En | MEDLINE | ID: mdl-32047951

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Osteoporosis Posmenopáusica / Alendronato / Fracturas Óseas / Conservadores de la Densidad Ósea / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans País/Región como asunto: Asia Idioma: En Revista: Osteoporos Int Asunto de la revista: METABOLISMO / ORTOPEDIA Año: 2020 Tipo del documento: Article País de afiliación: Hong Kong

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Osteoporosis Posmenopáusica / Alendronato / Fracturas Óseas / Conservadores de la Densidad Ósea / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans País/Región como asunto: Asia Idioma: En Revista: Osteoporos Int Asunto de la revista: METABOLISMO / ORTOPEDIA Año: 2020 Tipo del documento: Article País de afiliación: Hong Kong